Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®


Daily Low-Dose Subcutaneous Recombinant Interleukin-2 by Alternate Weekly Administration

Antitumor Activity and Immunomodulatory Effects

Tagliaferri, Pierosandro, M.D.; Barile, Carmen, M.D.; Caraglia, Michele, M.D.; Guarrasi, Rosario, M.D.; Morelli, Daniela, M.D.; Ricciardi, Beatrice, Ph.D.; Martignetti, Angelo, M.D.; Librera, Maria Teresa, M.D.; Matano, Elide, M.D.; Vecchia, Aldo Della, M.D.; Catalano, Giuseppe, M.D.; Famiani, Maurizio, M.D.; Palmieri, Giovannella, M.D.; Correale, Pierpaolo, M.D., Ph.D.; Bianco, Angelo Raffaele, M.D., Ph.D.

Author Information
American Journal of Clinical Oncology: February 1998 - Volume 21 - Issue 1 - p 48-53
  • Buy


© Lippincott-Raven Publishers.